Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ascorbic Acid Decreases Morphine Self-Administration and Withdrawal Symptoms in Rats Publisher



Alaei H1 ; Esmaeili M1 ; Nasimi A1 ; Pourshanazari A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Pathophysiology Published:2005


Abstract

Recent studies have indicated that the glutamatergic system is involved in the motivational aspects during the initiation of drug self-administration. Ascorbic acid (AA), an antioxidant vitamin, is released from glutamatergic neurons, and it modulates the synaptic action of dopamine and glutamate. In this study the AA effects on the self-administration of morphine and on the morphine withdrawal syndrome have been investigated. Wistar rats were allowed to self-administer morphine (1 mg/infusion) during 10 consecutive days for 2 h/session. The number of lever pressings was recorded. An intrapritoneal AA injection (500 mg/kg, i.p.), 30 min before morphine self-administration produced a significant decrease in the initiation of morphine self administration during all sessions. After the last test session morphine withdrawal symptom signs (MWS) were recorded after naloxone precipitation. Most of MWS (but not all) were decreased by AA application. In conclusion, AA may change the motivational processes underlying the morphine self-administration. © 2005 Elsevier Ireland Ltd. All rights reserved.
Other Related Docs
11. Effects of Angiotensin Ii and Captopril on Rewarding Propreties of Morphine, Indian Journal of Experimental Biology (2007)
17. Effect of Morphine Self-Administration on Water and Food Intake in Rat, Iranian Journal of Basic Medical Sciences (2007)
31. Forced Exercise Improves Passive Avoidance Memory in Morphine-Exposed Rats, Pakistan Journal of Biological Sciences (2009)
49. Importance of Gabapentin Dose in Treatment of Opioid Withdrawal, Journal of Clinical Psychopharmacology (2011)